In Specialty Pharma, Short Interst in Abbott (ABT), Endo (ENDP) and Valeant (VRX) Surge
Get Alerts ABT Hot Sheet
Price: $113.21 -0.24%
Rating Summary:
18 Buy, 10 Hold, 1 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 11
Rating Summary:
18 Buy, 10 Hold, 1 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 11
Join SI Premium – FREE
Providing commentary on the latest short interest data for the Specialty Pharmaceuticals space, Guggenheim's Louise Chen noted that for the period ended 05/13/16, the largest increase in short interest is Abbott (NYSE: ABT) at +307.3%. Notably, Abbott announced a deal to acquire St. Jude Medical, Inc (NYSE: STJ) during the period.
Meanwhile, the largest decrease in short interest was Pfizer (NYSE: PFE) at -22.3%.
Among heavily-shorted Specialty Pharmaceuticals stocks:
- Endo Pharmaceuticals (NASDAQ: ENDP) saw its short interest rise 51.3% to 9,137,196 shares.
- Valeant Pharmaceuticals (NYSE; VRX) saw its short interest rise 44.2% to 24,239,629 shares
- Mallinckrodt plc (NYSE: MNK) saw its short interest rise 11% to 12,799,313 shares.
- Horizon Pharma (NASDAQ: HZNP) saw its short interest rise 1.7% to 15,604,946 shares.
- Shire (NASDAQ: SHPG) saw its short interest fall 0.4% to 19,663,451 shares.
- Zoetis (NYSE: ZTS) saw its short interest fall 10% to 7,099,376 shares.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Take-Two acquisition, global M&A, UBS diligence - what's moving markets
- Kerrisdale Capital is short Microstrategy, Inc. (MSTR), long bitcoin
- Barclays Reinstates LondonMetric Property PLC (LMP:LN) (LNSPF) at Overweight
Create E-mail Alert Related Categories
Analyst Comments, Short Sales, Trader TalkRelated Entities
Definitive Agreement, Louise Chen, GuggenheimSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!